These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32066718)

  • 1. On the relationship of first-episode psychosis to the amphetamine-sensitized state: a dopamine D
    Weidenauer A; Bauer M; Sauerzopf U; Bartova L; Nics L; Pfaff S; Philippe C; Berroterán-Infante N; Pichler V; Meyer BM; Rabl U; Sezen P; Cumming P; Stimpfl T; Sitte HH; Lanzenberger R; Mossaheb N; Zimprich A; Rusjan P; Dorffner G; Mitterhauser M; Hacker M; Pezawas L; Kasper S; Wadsak W; Praschak-Rieder N; Willeit M
    Transl Psychiatry; 2020 Jan; 10(1):2. PubMed ID: 32066718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study.
    Slifstein M; van de Giessen E; Van Snellenberg J; Thompson JL; Narendran R; Gil R; Hackett E; Girgis R; Ojeil N; Moore H; D'Souza D; Malison RT; Huang Y; Lim K; Nabulsi N; Carson RE; Lieberman JA; Abi-Dargham A
    JAMA Psychiatry; 2015 Apr; 72(4):316-24. PubMed ID: 25651194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling sensitization to stimulants in humans: an [11C]raclopride/positron emission tomography study in healthy men.
    Boileau I; Dagher A; Leyton M; Gunn RN; Baker GB; Diksic M; Benkelfat C
    Arch Gen Psychiatry; 2006 Dec; 63(12):1386-95. PubMed ID: 17146013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphetamine-Induced Striatal Dopamine Release Measured With an Agonist Radiotracer in Schizophrenia.
    Frankle WG; Paris J; Himes M; Mason NS; Mathis CA; Narendran R
    Biol Psychiatry; 2018 Apr; 83(8):707-714. PubMed ID: 29325847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased release of dopamine in the striata of young adults with hearing impairment and its relevance for the social defeat hypothesis of schizophrenia.
    Gevonden M; Booij J; van den Brink W; Heijtel D; van Os J; Selten JP
    JAMA Psychiatry; 2014 Dec; 71(12):1364-72. PubMed ID: 25271822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between childhood trauma, dopamine release and dexamphetamine-induced positive psychotic symptoms: a [
    Dahoun T; Nour MM; McCutcheon RA; Adams RA; Bloomfield MAP; Howes OD
    Transl Psychiatry; 2019 Nov; 9(1):287. PubMed ID: 31712556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortical stress regulation is disrupted in schizophrenia but not in clinical high risk for psychosis.
    Schifani C; Tseng HH; Kenk M; Tagore A; Kiang M; Wilson AA; Houle S; Rusjan PM; Mizrahi R
    Brain; 2018 Jul; 141(7):2213-2224. PubMed ID: 29860329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional magnetic resonance imaging investigation of the amphetamine sensitization model of schizophrenia in healthy male volunteers.
    O'Daly OG; Joyce D; Stephan KE; Murray RM; Shergill SS
    Arch Gen Psychiatry; 2011 Jun; 68(6):545-54. PubMed ID: 21300940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of amphetamine-induced dopamine release by group II metabotropic glutamate receptor agonist LY354740 in non-human primates studied with positron emission tomography.
    van Berckel BN; Kegeles LS; Waterhouse R; Guo N; Hwang DR; Huang Y; Narendran R; Van Heertum R; Laruelle M
    Neuropsychopharmacology; 2006 May; 31(5):967-77. PubMed ID: 16177807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging Cortical Dopamine Transmission in Cocaine Dependence: A [
    Narendran R; Mason NS; Himes ML; Frankle WG
    Biol Psychiatry; 2020 Nov; 88(10):788-796. PubMed ID: 32507390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis.
    Robinson TE; Becker JB
    Brain Res; 1986 Jun; 396(2):157-98. PubMed ID: 3527341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous dopamine release in the human brain as a pharmacodynamic biomarker: evaluation of the new GPR139 agonist TAK-041 with [
    Rabiner EA; Uz T; Mansur A; Brown T; Chen G; Wu J; Atienza J; Schwarz AJ; Yin W; Lewis Y; Searle GE; Dennison JMTJ; Passchier J; Gunn RN; Tauscher J
    Neuropsychopharmacology; 2022 Jun; 47(7):1405-1412. PubMed ID: 34675381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single exposure to amphetamine is sufficient to induce long-term behavioral, neuroendocrine, and neurochemical sensitization in rats.
    Vanderschuren LJ; Schmidt ED; De Vries TJ; Van Moorsel CA; Tilders FJ; Schoffelmeer AN
    J Neurosci; 1999 Nov; 19(21):9579-86. PubMed ID: 10531460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic mechanisms mediating the long-term expression of locomotor sensitization following pre-exposure to morphine or amphetamine.
    Vanderschuren LJ; Schoffelmeer AN; Mulder AH; De Vries TJ
    Psychopharmacology (Berl); 1999 Apr; 143(3):244-53. PubMed ID: 10353426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D1-Dopamine Receptor Availability in First-Episode Neuroleptic Naive Psychosis Patients.
    Stenkrona P; Matheson GJ; Halldin C; Cervenka S; Farde L
    Int J Neuropsychopharmacol; 2019 Jul; 22(7):415-425. PubMed ID: 30958880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First human evidence of d-amphetamine induced displacement of a D2/3 agonist radioligand: A [11C]-(+)-PHNO positron emission tomography study.
    Willeit M; Ginovart N; Graff A; Rusjan P; Vitcu I; Houle S; Seeman P; Wilson AA; Kapur S
    Neuropsychopharmacology; 2008 Jan; 33(2):279-89. PubMed ID: 17406650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine-Related Disruption of Functional Topography of Striatal Connections in Unmedicated Patients With Schizophrenia.
    Horga G; Cassidy CM; Xu X; Moore H; Slifstein M; Van Snellenberg JX; Abi-Dargham A
    JAMA Psychiatry; 2016 Aug; 73(8):862-70. PubMed ID: 27145361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary data indicating a connection between stress-induced prefrontal dopamine release and hippocampal TSPO expression in the psychosis spectrum.
    Schifani C; Hafizi S; Tseng HH; Gerritsen C; Kenk M; Wilson AA; Houle S; Rusjan PM; Mizrahi R
    Schizophr Res; 2019 Nov; 213():80-86. PubMed ID: 30409695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disrupted relationship between blood glucose and brain dopamine D2/3 receptor binding in patients with first-episode schizophrenia.
    Sauerzopf U; Weidenauer A; Dajic I; Bauer M; Bartova L; Meyer B; Nics L; Philippe C; Pfaff S; Pichler V; Mitterhauser M; Wadsak W; Hacker M; Kasper S; Lanzenberger R; Pezawas L; Praschak-Rieder N; Willeit M
    Neuroimage Clin; 2021; 32():102813. PubMed ID: 34544031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging Microglial Activation in Untreated First-Episode Psychosis: A PET Study With [
    Hafizi S; Tseng HH; Rao N; Selvanathan T; Kenk M; Bazinet RP; Suridjan I; Wilson AA; Meyer JH; Remington G; Houle S; Rusjan PM; Mizrahi R
    Am J Psychiatry; 2017 Feb; 174(2):118-124. PubMed ID: 27609240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.